The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Dasatinib (D) in previously treated metastatic colorectal cancer (mCRC) patients: A phase II trial of the University of Chicago phase II consortium.
Manish Sharma
Disclosure not yet available
Kristen Wroblewski
Disclosure not yet available
Mark Kozloff
Disclosure not yet available
Sanjiv S. Modi
Disclosure not yet available
Bethany G. Sleckman
Disclosure not yet available
David Taber
Disclosure not yet available
Everett E. Vokes
Disclosure not yet available
Walter M. Stadler
Disclosure not yet available
Blase N. Polite
Disclosure not yet available
Hedy L. Kindler
Disclosure not yet available